| Literature DB >> 26270904 |
Bingbing Hu1,2, Fengying Dai3, Zhanming Fan4, Guanghui Ma1, Qunwei Tang2, Xin Zhang1.
Abstract
As nanotheranostics, Congo red/Rutin-MNPs combine the abilities of diagnosis and treatment of Alzheimer's disease (AD). The biocompatible nanotheranostics system based on iron oxide magnetic nanoparticles, with ultrasmall size and excellent magnetic properties, can specifically detect amyloid plaques by magnetic resonance imaging, realize targeted delivery of AD therapeutic agents, achieve drug controlled release by H2O2 response, and prevent oxidative stress.Entities:
Keywords: Alzheimer's disease; H2O2-responsive; magnetic resonance imaging; nanotheranostics; therapy
Mesh:
Substances:
Year: 2015 PMID: 26270904 DOI: 10.1002/adma.201502227
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849